JAK2 and essential thrombocythemia: And, in the10 years since the discovery of JAK2 mutations in MPNs, these lesions can be diagnostic of polycythemia vera (PV), essential thrombocythemia (ET), or primary myelofibrosis (PMF) in the appropriate clinical contexts [12].